C-RAD, a global leader in Surface Guided Radiation Therapy (SGRT), has received a 10 MSEK order from prominent US cancer center to equip a newly established satellite facility in Texas. The contract includes Catalyst+ HD™ and Sentinel™ 4DCT, supporting the clinic’s goal of initiating patient treatments in 2027.

By integrating C-RAD’s real-time motion monitoring and positioning solutions, the center is reinforcing its commitment to precision, safety, and workflow efficiency in radiation therapy.

“This agreement represents a significant milestone in C-RAD’s strategic expansion into one of Texas’ most advanced and respected healthcare institutions. We are especially proud to continue our collaboration with this valued customer. Their renewed trust in our SGRT systems reflects not only the clinical value we deliver but also the strength of our long-term partnership and commitment to supporting world-class cancer care,” says Cecilia de Leeuw, CEO and President of C-RAD.

For further information:

Cecilia de Leeuw, CEO, +46 (0)795 85 66 77, investors@c-rad.com
Linda Frölén, CFO, +46 (0)703 03 32 53, investors@c-rad.com

About C-RAD

C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit http://www.c-rad.com

Attachments

C-RAD Expands US Footprint with 10 MSEK Order to Equip Leading Texas Cancer Center with Surface Guided Radiation Therapy Solutions

Läs mer på MFN